HARBOR CAPITAL ADVISORS, INC. – Alnylam Pharmaceuticals, Inc. Transaction History
HARBOR CAPITAL ADVISORS, INC. portfolio value:
$79,000
portfolio value
HARBOR CAPITAL ADVISORS, INC. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -67.14% | -811 shares | -97K | $200.16 | 397 |
| Q2 2022 | share | Increase | +9.82% | 108 shares | -4K | $145.85 | 1.20K |
| Q1 2022 | share | Increase | 0.00% | 1.1K shares | 180K | $163.29 | 1.1K |